Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids.
about
Exhaled nitric oxide measurements: clinical application and interpretationThe safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline'Indirect' challenges from science to clinical practiceRevisiting early intervention in adult asthmaInhaled CorticosteroidsAirways disease: phenotyping heterogeneity using measures of airway inflammation.Clinical patterns in asthma based on proximal and distal airway nitric oxide categoriesAn open-label study examining the effect of pharmacological treatment on mannitol- and exercise-induced airway hyperresponsiveness in asthmatic children and adolescents with exercise-induced bronchoconstriction.Alternaria-derived serine protease activity drives IL-33-mediated asthma exacerbationsProof of concept study to evaluate step-down therapy with inhaled corticosteroid alone or additive therapy on surrogate inflammatory markers in asthmaAsthma, airway biology, and nasal disorders in AJRCCM 2001.Risk factors for montelukast treatment failure in step-down therapy for controlled asthmaStepping down inhaled corticosteroids in asthma: randomised controlled trial.Mechanisms of airway hyper-responsiveness in asthma: the past, present and yet to come.Biomarker-based asthma phenotypes of corticosteroid response.Perception of airway narrowing during reduction of inhaled corticosteroids and asthma exacerbation.Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission.Clinical usefulness of inflammatory markers in asthma.Factors controlling airway smooth muscle proliferation in asthma.Exhaled breath condensate in children: pearls and pitfalls.Does bronchial hyperresponsiveness in asthma matter?Monitoring response to treatment in asthma management: food for thought.Managing asthma in the real world.Single-dose agents in the prevention of exercise-induced asthma: a descriptive review.Recent developments in asthma managementVentilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation.Biomarkers predicting response to corticosteroid therapy in asthma.Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practiceAirway Smooth Muscle Dynamics and Hyperresponsiveness: In and outside the Clinic.Diagnosing occupational asthma: insight from induced sputum.Non-invasive measurement of airway inflammation in asthma.Predictors of loss of asthma control induced by corticosteroid withdrawalEffects of add-on montelukast on airway hyperresponsiveness in patients with well-controlled asthma - a pilot studyMarkers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study.Partitioned exhaled nitric oxide to non-invasively assess asthma.Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives.The role of measuring airway hyperresponsiveness and inflammatory biomarkers in asthmaEffect of fluticasone 250 microg/salmeterol 50 microg and montelukast on exhaled nitric oxide in asthmatic patients.The use of exhaled nitric oxide in the management of asthma.Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control.
P2860
Q24678480-ADD95763-54C4-4149-9DFC-735237C8A0A3Q25255964-4B1629E2-39D5-4457-B57A-E60864540B96Q26767035-73FB1306-0A71-4E85-B92F-84F9A6357C94Q28071831-BA282759-75A7-4A32-9718-BE14F701AF3DQ33664193-D1DD397F-1AC8-4160-87D7-4B7AFB62FE4DQ33864952-6B3FAFF9-2BC2-4367-B4AC-59C63A7895C6Q33875389-6A91A49B-0818-4869-AE81-4B108F5333A3Q34062204-34CE15DA-C5B5-4789-BBD6-95B8B357CDDAQ34121201-61D7215D-0BDF-4E7E-8BB7-4F63385A7606Q34476137-90F7E13E-BA4A-47A7-BD02-9E4A92F32350Q34550135-33AF69CF-D324-4009-AB42-21278234BFBCQ34778001-586A702B-0C29-4E6F-8268-CCD9F72C5C9EQ35017368-599BD771-D528-46C5-94A4-BB93949050A9Q35282054-640919C9-C148-4E81-B2E6-C27B9355F5BFQ35305384-B2E6EAE2-81C1-47B1-996B-E2715E9C8B54Q35535600-13D0211D-3A9B-472B-A104-DBBEFE5F35DDQ35537520-7297259B-56A2-4EA2-A228-B22B123123CBQ35627739-020E1662-868C-4B98-A1C0-DDBFD3D97354Q35652259-E99F1323-EA34-443A-A04A-DA5399B7AA9BQ35681249-AE1D9D48-9575-4F47-958F-A742CC205183Q35839483-21EEA365-844F-428C-8005-809A1133BEBEQ35857828-15A30FC7-46F3-4786-9209-D114AD99E521Q35863166-F8635863-8BA5-4325-9CDC-75105D270F9CQ36013683-CC8FC766-9459-4076-A6E9-96242094375FQ36067978-167400BD-1A5F-498E-A5B0-DF02C0E4886BQ36225845-DF5E1951-7C4F-48F6-93A2-D6D932B24D58Q36246749-59FD43C4-5242-4071-9E6E-7A84D67AA01BQ36332206-54CA57A1-6FFB-408B-9B65-26AB34DD8ECDQ36355423-B9C80D90-2EBC-46F7-A353-A25F8A05F799Q36538323-FFDAD2E8-4901-46CC-8DDA-159431BD84E0Q36585609-EBCCF1CB-5B63-4984-A915-9A9C0DFA2FF3Q36883469-46DACE50-DC1F-47F9-A996-1BD0E637ECCAQ37077214-95880C61-30AD-4362-B5E4-F6523AF2B5B1Q37082641-03B60EDD-126B-486A-B5B6-6EF78CD812CAQ37097729-A4C561E6-ECAD-4782-9A39-076A3F034D2BQ37115894-E82C4E61-FF7D-428B-91BB-EA29CA1C6B78Q37116793-E8C62308-0C3B-4925-B905-9258DB21D8C8Q37181742-64E89846-1057-4628-9625-6B18547FD1F8Q37261439-E6F2BF19-4478-4A8B-8FAB-6D47C9995335Q37274731-279A0A6B-258C-4267-8023-C89B32801BC2
P2860
Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Predictive markers of asthma e ...... on of inhaled corticosteroids.
@ast
Predictive markers of asthma e ...... on of inhaled corticosteroids.
@en
type
label
Predictive markers of asthma e ...... on of inhaled corticosteroids.
@ast
Predictive markers of asthma e ...... on of inhaled corticosteroids.
@en
prefLabel
Predictive markers of asthma e ...... on of inhaled corticosteroids.
@ast
Predictive markers of asthma e ...... on of inhaled corticosteroids.
@en
P2093
P2860
P1476
Predictive markers of asthma e ...... ion of inhaled corticosteroids
@en
P2093
Anderson SD
Andersson M
Brannan JD
Woolcock AJ
P2860
P304
P356
10.1164/AJRCCM.163.2.9912091
P407
P577
2001-02-01T00:00:00Z